MYB and neoplasm: MiR-29a and miR-150 were both shown to be tumor suppressors that, respectively, sensitized NPM-ALK(+) ALCL cells to doxorubicin-induced apoptosis through MCL-1 targeting, and reduced cell growth and viability through MYB [8, 18].